Resistance to first line anti-malarial drugs is increasing on the Thai-Myanmar border
Early diagnosis and treatment with antimalarial drugs (ACTs—artemisinin based combination treatments) has been linked to a reduction in malaria in the migrant population living on the Thai-Myanmar border, despite evidence of increasing resistance to ACTs in this location, according to a study by international researchers published in this week's PLOS Medicine.
These findings are important as this study suggests that alternative treatments are urgently needed to replace the failing first line drug regimen (mefloquine and artesunate).
The authors, led by François Nosten ...

